Data from a population of patients with rheumatoid arthritis in a Norwegian clinic (∼33% receiving biologic DMARDs) show that the proportions of those achieving remission or low disease activity improved significantly between 2004 and 2013. Remission rates, determined using various criteria, increased from 3.8–21.3% to 17.7–55.5% over the 10 years.
References
Haugeberg, G. et al. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res. Ther. doi:10.1186/s13075-015-0716-0
Rights and permissions
About this article
Cite this article
10 years of improving remission rates and disease activity. Nat Rev Rheumatol 11, 562 (2015). https://doi.org/10.1038/nrrheum.2015.124
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2015.124
